Dr. Subadra Dravida
Founder & CEO
Transcell Biologics, India
In Asia Pacific region, India’s biotech industry is the third largest in Asia-Pacific and is on the cusp of get in a new era. This all has been possible due to the government’s focus on the sector, whether it is concern to increase in investments, outsourcing activities and exports. The country is also able to produce a strong pool of scientists and engineers who are proficient of developing cost-effective manufacturing capabilities.
Moreover, concrete steps taken in direction of setting up of national research laboratories, supporting new start-ups by governments, excellent academic centers and several other institutes in medical science, educational and training institutes offering degrees and diplomas in biotechnology, bio-informatics and biological sciences have given a boom to biotechnology and healthcare sector.
As per the make in India statistics, the sector’s market size is expected to escalate to USD 11.6 Billion by 2017. All this will take place due to factors such as strong government initiatives, intensive demand for healthcare services, fast-growing of clinical capabilities, tremendous R&D activities and with the country becoming a popular harbour for global companies for clinical trials, contract research and manufacturing activities. Furthermore, The Indian biotech industry is expected to grow at an average growth rate of around 30% a year and touch USD 100 Billion by 2025. Also, these start-ups have proffered pertinent marketplaces to e-connect and bridge directly to suppliers without middle man.
S Dravida is the Founder and CEO of Transcell Biologics, Hyderabad, Telangana, India.Dr. Dravida is also the inventor of all of the patented and proprietary processes used by Transcell’s labs today in processing, formulating and preserving the clinical grade stem cells harvested from established clinical sources. S Dravida, a pioneering biotech entrepreneur in the stem cell domain, has been instrumental in shaping the Company’s vision and mission as fully-integrated, innovation-led, emerging enterprise committed to technology advancements and reaching the patient community. As a global face, she represents first generation women entrepreneurs with 15+ years of domain experience in commercialization and translating science to business opportunities. She is a member of Stem Cell Society Of India and also into consulting, technology outsourcing solutions. She has won national and international grants and projects in stem cells applications and productizations. The latest to her acclaim were TIE-Diamonds in rough award 2013-14, Make in India - Women Entrepreneur Award 2016, All India Achiever's Award 2016, India Russia Bridge Innovation (IRBI) Entrepreneur 2016.
Anuradha Acharya, CEO of Mapmygenome India, a genomics company whose vision is "Better health using technology". She is a Co-Founder of Ocimum Biosolutions, which she led as the CEO (2000-March 2013). She is an alumnus of IIT Kharagpur and University of Illinois where she has two Postgraduate degrees in Physics and MIS.Women Ahead (Jio Economic Times Start up Awards 2015) Member of Young Leaders Forum (British High Commission, 2013) Young Global Leader (World Economic Forum (WEF) 2011) Entrepreneur of the Year (Biospectrum, 2008) Astia Life Science Innovators Award (2008) 25 Tech Titans under 35 (Red Herring, 2006). Current Board positions include Global Agenda Council on Genetics for WEF NIBMG (Governing Board Member)
Shivendra Bajaj is the Executive Director of the Association of the Biotech Led Enterprises- Agriculture Focus Group (ABLE-AG). With over 20 years of experience in the field of biotechnology, Dr. Bajaj joins ABLE – AG from DuPont Pioneer where he held positions of National Biotech Regulatory Cooperation Lead and China and Asia Pacific Regulatory Science and Operations Lead and was responsible for generation of data required for the approval of biotech crops in Asia Pacific countries.Shivendra has worked several years overseas in the area of developing biotech crops and worked for Monsanto in India and was one of the key members of team responsible for regulatory approval of insect resistant Bt cotton in India.
Ujwala V. Salvi has over 15 years of experience across the global and local Pharmaceutical/CRO, Tier I Medical Devices and BPO industry. A MBA from Indian Institute of Management, Kolkata, Doctorate in Applied biology, trained Six Sigma Black Belt and various Project management tools, with core Experience in a wide range of Therapeutic Areas, and worked at all stages of clinical development from Phase II to production of clinical documentation necessary for product license applications. She has worked in large global operations, managed strategic relationships, and played a key role in winning new business, setting up off-shored partnerships and in identifying new BU service lines and growing existing ones. Her areas of expertise include Clinical Trial operations, Risk Based Monitoring, Medical Writing and data publication, Clinical Data Management, and feasibilities of new drug development and Analytics.She is an industry expert, has been involved in key global industry forums such as the DIA, SCDM, CII and CPHI.
Ram N Kumar aged 34 years, is the Founder and CEO of NirogStreet. NirogStreet aims to make Ayurveda mainstream and first line of treatment for billions of people by curating, training and introducing best practices in traditional system of medicine practice using information technology and cutting edge research for Ayurveda medicine. After having key role in IT and advertising, he moved on to start digital technology company “Marketech” which was later merged with Razorse Software Private Limited, a product centric technology services company. He also serves in the board of not for profit think tank "Centre for Civil Initiatives". He has been conferred many recognition which includes BW "Torch Bearer of Ayurveda Award" by Hon'ble Minister of Communications (IC) Shri Manoj Sinha in May 2017 at Oja Festival. Other recognition includes technology person in Media domain 2014, Social IOT influencer at Mint IOT day 2015. He is also guest faculty at various Institutions of excellence like NIFT, JRE College, NDIM and speaker at various forums on Healthcare, Marketing and Technology.
T. Charles John Bhaskar, the Scientist and Managing Director of GeoMarine Biotechnologies (P) Ltd, one of the very few Marine Biotechnology companies in India. He is also the scientific leader of Alpha & Omega Consultants. He has a fervent zeal for social works too. As scientist leader of Alpha & Omega Consultants, Dr. Charles developed a technology for the first indigenous probiotics for aquaculture in India. A technology that not only showed important advances, but also produced a stream of competitors opening a new era of "aquaculture probiotics," which otherwise had only been imported. "Very few would have thought that the indigenous probiotics for aquaculture could change the scenario of aquaculture until in 1999 the first commercial probiotics were released into the market," said Charles. For this achievement, he was nominated for Indigenous Commercialization Award at Department of Science and Technology (Govt. of India).